The Quality Lowdown: What Happens When The US FDA Must Choose Between Risks
Executive Summary
Tuberculosis or cancer, sterility assurance or shortages, the choices come at you fast; Takeda, Wintac, Banco Vida updates.
You may also be interested in...
The Quality Lowdown: Yes, The US FDA Expects You To Heed Import Alerts And Testing Requirements
PCCA repackaged adulterated APIs, Allay failed to understand processes, ShangRao and Mexican firms peddled subpotent, sometimes methanol-tainted ethanol.
Nitrosamine Concerns Spur Precautionary Testing Of Rifampicin In EU
National regulators throughout the EU will ask manufacturers of rifampicin-containing medicines to check their products for nitrosamine impurities before they are released for sale.
COVID-19 Shows US FDA Why It Needs To Know Supply Chain’s Current And Surge Capacities
Agency begins gathering manufacturing plant data to prepare for disruptions that can drain inventories over a weekend.